Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02701829 · ClinicalTrials.gov registry record · NA

Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
166
Enrollment target

NCT02701829: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02701829 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02701829, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
166 participants
Enrollment target

Study Summary

In our past work it was found that many drivers had high blood pressure, and lifestyles that led to being overweight and not having cancer screenings performed. The investigators are now adding to the Health Fairs' usual program different ways of following up with drivers who attend our Health Fairs. The investigators are doing this because they want to find the best way to help drivers manage high blood pressure, and reduce cancer risk, by maintaining a healthy weight and increasing colorectal cancer screening. Health screenings will be conducted by trained personnel, and a physician or nurse will provide a health consult in person or over the phone (via MSK-issued phone/video/audio devices). In the event that participants are unable to meet in person for biometric measurements, staff will accept their self-reported weight, blood pressure, and waist circumference over the phone. Staff may mail blood pressure machines (to participants who did not receive them at baseline), scales, and measuring tapes to participants to assist in the completion of self-reported biometric measures. Along with supplies, participants may also receive a letter asking for the confirmation of supply receipt. \* If critically abnormal values are identified during the health fair, under the advisement of the clinician, the driver may be escorted by trained staff directly to a health care facility for immediate medical follow-up

Primary Outcome

The drop in BP from baseline will be estimated for each participant. The investigators will summarize the mean and 95% confidence interval (CI) for the drop in systolic and diastolic BP from baseline for each arm at the

Interventions

  • OTHER CONTROL- Usual & Customary Health Fair Follow-up
  • OTHER Health Fair + TECH [Text Messaging + Home Blood Pressure Monitoring]
  • OTHER Heal th Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] + Social Network Support (SNS)

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2016-02
Est. Completion 2025-10-27
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT02701829 record still lists

NCT02701829 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 3 interventions - of which CONTROL- Usual & Customary Health Fair Follow-up is the first listed.

NCT02701829 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02701829 about?

NCT02701829 is a clinical study titled "Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support". In our past work it was found that many drivers had high blood pressure, and lifestyles that led to being overweight and not having cancer screenings performed. The investigators are now adding to the Health Fairs' usual program different ways of following up with drivers who attend our Health Fairs...

What is the current status of trial NCT02701829?

This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2016-02. Estimated completion is 2025-10-27.

What interventions are being tested in trial NCT02701829?

The interventions under investigation include: CONTROL- Usual & Customary Health Fair Follow-up (OTHER), Health Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] (OTHER), Heal th Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] + Social Network Support (SNS) (OTHER).

Who is sponsoring clinical trial NCT02701829?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02701829's enrollment target sits among peer trials

166 625th of 2000 higher than 1,375 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02747303 · 166 participants · Phase 2

    Frameless Stereotactic Radiosurgery for Intact Brain Metastases

  • NCT03806283 · 166 participants

    Mechanisms of Pregnancy Vascular Adaptations

  • NCT04040452 · 166 participants · Phase 4

    Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

  • NCT04375813 · 166 participants · Phase 2

    Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02701829, the US trial registry maintained by the National Library of Medicine. NCT02701829 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.